MedCity News July 10, 2019
The company has signed an initial partnership with Genentech that will focus on understanding the genetic components that are related to a person’s risk of developing ocular diseases like macular degeneration.
Medicare Advantage startup Clover Health has started a biopharmaceutical division called Clover Therapeutics meant to use data on the insurance plans’ members to help inform the development of new therapies for age-related chronic diseases.
The company has signed an initial partnership with Genentech that will focus on understanding the genetic components that are related to a person’s risk of developing ocular diseases like macular degeneration.
The two organizations will work together on designing studies, collecting samples and analyzing resulting data.
Cheng Zhang, the head of Clover Therapeutics, tied his...
Today's Sponsors
Today's Sponsor